Literature DB >> 15923407

Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.

Stuart G Baker1, Garrett M Fitzmaurice, Laurence S Freedman, Barnett S Kramer.   

Abstract

In randomized trials with missing or censored outcomes, standard maximum likelihood estimates of the effect of intervention on outcome are based on the assumption that the missing-data mechanism is ignorable. This assumption is violated if there is an unobserved baseline covariate that is informative, namely a baseline covariate associated with both outcome and the probability that the outcome is missing or censored. Incorporating informative covariates in the analysis has the desirable result of ameliorating the violation of this assumption. Although this idea of including informative covariates is recognized in the statistics literature, it is not appreciated in the literature on randomized trials. Moreover, to our knowledge, there has been no discussion on how to incorporate informative covariates into a general likelihood-based analysis with partially missing outcomes to estimate the quantities of interest. Our contribution is a simple likelihood-based approach for using informative covariates to estimate the effect of intervention on a partially missing outcome in a randomized trial. The first step is to create a propensity-to-be-missing score for each randomization group and divide the scores into a small number of strata based on quantiles. The second step is to compute stratum-specific estimates of outcome derived from a likelihood-analysis conditional on the informative covariates, so that the missing-data mechanism is ignorable. The third step is to average the stratum-specific estimates and compute the estimated effect of intervention on outcome. We discuss the computations for univariate, survival, and longitudinal outcomes, and present an application involving a randomized study of dual versus triple combinations of HIV-1 reverse transcriptase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923407     DOI: 10.1093/biostatistics/kxi038

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  10 in total

1.  Missing data in clinical studies: issues and methods.

Authors:  Joseph G Ibrahim; Haitao Chu; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.

Authors:  C Hendricks Brown; Wei Wang; Sheppard G Kellam; Bengt O Muthén; Hanno Petras; Peter Toyinbo; Jeanne Poduska; Nicholas Ialongo; Peter A Wyman; Patricia Chamberlain; Zili Sloboda; David P MacKinnon; Amy Windham
Journal:  Drug Alcohol Depend       Date:  2008-01-22       Impact factor: 4.492

Review 3.  Randomized trials with missing outcome data: how to analyze and what to report.

Authors:  Rolf H H Groenwold; Karel G M Moons; Jan P Vandenbroucke
Journal:  CMAJ       Date:  2014-04-28       Impact factor: 8.262

4.  Person mobility in the design and analysis of cluster-randomized cohort prevention trials.

Authors:  Sam Vuchinich; Brian R Flay; Lawrence Aber; Leonard Bickman
Journal:  Prev Sci       Date:  2012-06

5.  Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?

Authors:  Portia C Mutevedzi; Richard J Lessells; Tom Heller; Till Bärnighausen; Graham S Cooke; Marie-Louise Newell
Journal:  Bull World Health Organ       Date:  2010-05-10       Impact factor: 9.408

6.  A Multiprocess Item Response Model for Not-Reached Items due to Time Limits and Quitting.

Authors:  Esther Ulitzsch; Matthias von Davier; Steffi Pohl
Journal:  Educ Psychol Meas       Date:  2019-10-21       Impact factor: 2.821

7.  Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Authors:  Stuart G Baker; Amy K Darke; Paul Pinsky; Howard L Parnes; Barnett S Kramer
Journal:  Biostatistics       Date:  2010-02-19       Impact factor: 5.899

8.  Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).

Authors:  Eric M Ammann; James V Pottala; Jennifer G Robinson; Mark A Espeland; William S Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-06-15       Impact factor: 4.006

9.  Maximum likelihood estimation with missing outcomes: From simplicity to complexity.

Authors:  Stuart G Baker
Journal:  Stat Med       Date:  2019-08-08       Impact factor: 2.373

10.  A survey of laboratory and statistical issues related to farmworker exposure studies.

Authors:  Dana B Barr; Doug Landsittel; Marcia Nishioka; Kent Thomas; Brian Curwin; James Raymer; Kirby C Donnelly; Linda McCauley; P Barry Ryan
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.